title: Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.
abstract: Due to the low fidelity of the RNA-dependent RNA polymerase, Hepatitis C virus (HCV) mutates quite frequently. There are seven genetically divergent genotypes (GTs) distributed in the world, each of which contains several closely related subtypes. The peer-reviewed literatures reporting the prevalence rate of HCV GTs in Chinese hospitalized patients were identified by systematic searching of three electronic databases, and the prevalence rates were pooled through 137 qualified studies. The significant difference between HCV GT and HCV viral load and severity of hepatitis were analyzed under Chi-squared or Fisher's exact test. Data from epidemiological studies on hospitalized patients demonstrated that HCV GTs 1-6 have been found in China, of which 1b (62.78%(95% CI: 59.54-66.02%)) and 2a (17.39% (95% CI: 15.67-19.11%)) are the two predominant subtypes. HCV GTs and subtypes exhibits significant regional divergence. In North, Northwest, Northeast, East (except Jiangxi province) and Central China (except Hunan province), HCV-1b, 2a remain the two predominant subtypes; South China shows the most abundant genetic diversity that 14 subtypes were found, and HCV-3 in the Southwest China remains higher prevalent subtype than the other regions. In addition, co-infection in Liaoning province of Northeast China is the most diverse with 10 co-infection types, and Tibet has the highest rate of co-infection. The associations between HCV GTs and patients group, severity of illness and antiviral treatment efficacy were also discussed in this review.
authors.affiliation: Institute of Blood Transfusion, Peking Union Medical College, Chinese Academy of Medical Sciences, Chengdu, 610052, China.|Sichuan Blood Safety and Blood Substitute, International Science and Technology Cooperation Base, Chengdu, 610052, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Institute of Blood Transfusion, Peking Union Medical College, Chinese Academy of Medical Sciences, Chengdu, 610052, China.|Sichuan Blood Safety and Blood Substitute, International Science and Technology Cooperation Base, Chengdu, 610052, China.|Toronto General Research Institute, University of Toronto, Toronto, ON, Canada.
authors.forename: Li-Min
authors.initials: LM
authors.lastname: Chen
authors.affiliation: Institute of Blood Transfusion, Peking Union Medical College, Chinese Academy of Medical Sciences, Chengdu, 610052, China. messa1022@126.com.|Sichuan Blood Safety and Blood Substitute, International Science and Technology Cooperation Base, Chengdu, 610052, China. messa1022@126.com.
authors.forename: Miao
authors.initials: M
authors.lastname: He
mesh_terms: D002681:China / Q000453:epidemiology; D005838:Genotype; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000453:epidemiology* / Q000473:pathology / Q000821:virology*; D006801:Humans; D015995:Prevalence; D019562:Viral Load
keywords: Antiviral treatment efficacy; Co-infection; Distribution; HCV genotype; Population demographics; Subtypes